company background image
SHC

Sotera Health NasdaqGS:SHC Stock Report

Last Price

US$20.27

Market Cap

US$5.7b

7D

3.9%

1Y

-15.5%

Updated

15 Aug, 2022

Data

Company Financials +
SHC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance4/6
Financial Health2/6
Dividends0/6

SHC Stock Overview

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally.

Sotera Health Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sotera Health
Historical stock prices
Current Share PriceUS$20.27
52 Week HighUS$27.38
52 Week LowUS$17.73
Beta0
1 Month Change9.63%
3 Month Change3.84%
1 Year Change-15.54%
3 Year Changen/a
5 Year Changen/a
Change since IPO-19.24%

Recent News & Updates

Aug 04

Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M

Sotera Health press release (NASDAQ:SHC): Q2 GAAP EPS of $0.11 misses by $0.05. Revenue of $266.64M (+5.8% Y/Y) beats by $10.34M. Adjusted EBITDA for the second-quarter 2022 increased 1.2% over the second quarter of 2021 to $136M.  FY 2022 Guidance: Net revenues in the range of $1.0 to $1.022 billion, from previous guidance of $1.0 to $1.03 billion, representing growth of approximately 7% to 10%, compared to the prior year, vs. consensus of $1.02B Adjusted EBITDA in the range of $515 to $525 million, from previous guidance of $515 to $535 million, representing growth of approximately 7% to 9%, compared to the prior year Adjusted EPS in the range of $0.93 to $0.97 from previous guidance of $0.93 to $0.99 representing growth of 6% to 10% versus the prior year, vs. consensus of $0.96. Capital expenditures in the range of $140 million to $170 million

Shareholder Returns

SHCUS Life SciencesUS Market
7D3.9%3.6%3.6%
1Y-15.5%-19.7%-9.6%

Return vs Industry: SHC exceeded the US Life Sciences industry which returned -19.8% over the past year.

Return vs Market: SHC underperformed the US Market which returned -10.2% over the past year.

Price Volatility

Is SHC's price volatile compared to industry and market?
SHC volatility
SHC Average Weekly Movement6.4%
Life Sciences Industry Average Movement10.8%
Market Average Movement7.7%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: SHC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: SHC's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20173,000Michael Petrashttps://soterahealth.com

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company’s sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries.

Sotera Health Company Fundamentals Summary

How do Sotera Health's earnings and revenue compare to its market cap?
SHC fundamental statistics
Market CapUS$5.66b
Earnings (TTM)US$123.08m
Revenue (TTM)US$970.81m

46.6x

P/E Ratio

5.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SHC income statement (TTM)
RevenueUS$970.81m
Cost of RevenueUS$432.00m
Gross ProfitUS$538.81m
Other ExpensesUS$415.73m
EarningsUS$123.08m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.44
Gross Margin55.50%
Net Profit Margin12.68%
Debt/Equity Ratio274.5%

How did SHC perform over the long term?

See historical performance and comparison